<DOC>
	<DOCNO>NCT01055899</DOCNO>
	<brief_summary>This study test safety tolerability ( body reacts drug ) REGN88 placebo ( inactive substance contains medicine ) patient Rheumatoid Arthritis .</brief_summary>
	<brief_title>Safety Study Single Dose REGN88 ( SAR153191 ) Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description>This multi-center , randomize , double blind , placebo-controlled , single dose escalation study safety tolerability subcutaneously administer REGN88 rheumatoid arthritis patient receive concomitant methotrexate . Three ( 3 ) sequential dose cohort 5 subject ( 4:1 active : placebo ) dose SC REGN88 placebo . Subjects complete study participate 14 study visit 16 week .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>1 . Male female â‰¥ 18 year age 2 . Subjects must weigh &gt; 50 kg &lt; 100 kg 3 . Diagnosis Rheumatoid Arthritis ( RA ) define 1987 revised American College Rheumatology ( ACR ) criteria disease duration le 6 month ACR class IIII 4 . For woman childbearing potential , negative serum pregnancy test Screening Visit ( Visit 1 ) negative urine pregnancy test Day 1 5 . For men woman childbearing potential , willingness utilize adequate contraception become pregnant ( partner [ ] become pregnant ) full course study . 1 . A history Listeriosis active tuberculosis ( TB ) 2 . Persistent chronic active recur infection require treatment antibiotic , antiviral , antifungal within 4 week prior Screening Visit 3 . History prior articular prosthetic joint infection 4 . History hypersensitivity reaction , localize injection site reaction ( ISR ) , biological molecule 5 . Significant concomitant illness , limited cardiac , renal , neurological , endocrinological , metabolic lymphatic disease would adversely affect subject 's participation study 6 . Received administration live ( attenuate ) vaccine within 3 month prior Screening Visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>RA</keyword>
</DOC>